SKIN ATLAS · ACTIVE INGREDIENT · 4 MIN. READ

NMN & NAD+ Boost: Cellular Energization as the Basis for Skin-Specific Longevity

Nicotinamide mononucleotide (NMN) is a naturally occurring nucleotide precursor of the coenzyme nicotinamide adenine dinucleotide (NAD+), which acts as a central electron carrier and regulatory metabolite in every human cell. With increasing age, intracellular NAD+ levels measurably decline — a process associated with reduced DNA repair capacity, impaired mitochondrial function, and increased cellular senescence. NMN is considered one of the most biochemically direct ways to address this decline, both topically and systemically.

Term and Origin

The term "Nicotinamide Mononucleotide" derives from nucleotide biochemistry nomenclature: Nicotinamide refers to the amide form of nicotinic acid (Vitamin B3), Mono indicates the single phosphate group, and Nucleotide describes the basic configuration of a nucleoside and phosphate. NMN was described as an intermediate metabolite of the NAD+ biosynthesis pathway as early as the 1960s, but only gained broader scientific attention through the work of David Sinclair (Harvard Medical School) and Shin-ichiro Imai (Washington University) from about 2013 onwards. Imai et al. demonstrated in mouse models that oral NMN supplementation can significantly improve age-associated physiological parameters — a finding that triggered intensive follow-up research.

In the context of skin biology, NMN is part of a larger discourse, conducted under the term Skin Longevity & NAD/NMN. The scientific classification follows the logic of Skin Longevity research: skin is no longer primarily considered a passive protective organ, but a metabolically highly active tissue whose functionality directly depends on the availability of bioenergetic cofactors.

In parallel to NMN, Nicotinamide Riboside (NR) is discussed as an alternative NAD+ precursor; both substances converge in the so-called salvage pathway — the recycling pathway for nicotinamide. NMN has a structure extended by a phosphate group compared to NR and is biochemically considered to be immediately upstream of NAD+, which potentially favors its synthesis efficiency.

Characteristics & Mechanism of Action

NAD+ fulfills a dual function in keratinocytes and fibroblasts: As a redox cofactor, it transfers hydride ions in the mitochondrial electron transport, thus enabling ATP synthesis. As a substrate for regulatory enzymes — particularly Sirtuin deacetylases (SIRT1–SIRT7) and the PARP family (Poly-ADP-ribose polymerases) — it controls chromatin modification, DNA strand break repair, and inflammatory signaling pathways. An NAD+ deficiency therefore means not only a reduction in energy supply but also a systemic limitation of cellular protective and regulatory processes. This connection is particularly well documented in research on Inflammaging and silent skin aging.

The age-related NAD+ decline — quantified in human skin biopsies at up to 50% of the levels in young adults — is explained by several converging mechanisms: increased consumption by overactivated PARPs due to accumulated DNA damage, decreased expression of the key enzyme NAMPT (Nicotinamide Phosphoribosyltransferase), and increased CD38 activity, an NAD+-consuming hydrolase whose expression increases with age. NMN partially bypasses the NAMPT step, which is considered rate-limiting, by being directly phosphorylated to NAD+ by NMNAT enzymes (Nicotinamide Mononucleotide Adenylyltransferases). In this context, NMN is closely functionally related to Antioxidants, as activated sirtuins enhance antioxidant defense by deacetylating FOXO transcription factors and PGC-1α — a mechanism that directly counteracts oxidative skin aging.

Topically applied NMN must overcome the skin barrier and be absorbed into keratinocytes to become active intracellularly. Studies show that keratinocytes have specific transporter mechanisms — including Slc12a8 — that can transport NMN directly into the cell without the detour via extracellular cleavage to NAM. The stability of NMN in aqueous formulations is pH-dependent and benefits from buffered, slightly acidic environments (pH 5.5–6.5).

Skincare Approach

In topical cosmetics, NMN is primarily used in highly concentrated serum formulations designed to maximize penetration depth. Recommended active concentrations in dermatologically oriented formulations are between 0.5% and 3%, with penetration efficiency significantly enhanced by delivery systems such as liposomes or nanoparticles. NATURFACTOR® formulates without NMN. The Porcelain Skin Serum and the Blue Crystal Drops instead follow the timing of the skin's own processes – moisture and barrier during the day, regeneration at night.

In layering a modern facial care routine, NMN is ideally applied after cleansing and before occlusive emollient layers — analogous to the sequence logic that applies to facial serums: from the lowest to the highest texture viscosity. The combination with stable antioxidants such as vitamin C or vitamin E is biochemically sensible, as both substance classes act synergistically on mitochondrial redox homeostasis. Here, it is advisable to consider founded principles of combining active ingredients to take formulation compatibilities into account. Additionally, NMN can be well integrated into rhythm-based care concepts, such as those described in the Skin Cycling approach, as the circadian regulation of SIRT1 potentially favors the effectiveness of nocturnal applications.

For skin showing signs of premature aging or reduced barrier function — such as dehydrated skin — the combination with barrier-supporting active ingredients like ceramides is recommended, as an intact lipid barrier is a necessary prerequisite for efficient transdermal active ingredient absorption. Further information on the role of NAD+ and NMN in the context of skin aging is provided in the article Skin Longevity: What Science Says About NAD+ and NMN.

Realistic Expectations

NMN is not an instantly visible active ingredient in the sense of hydration or optical smoothing. Its effect unfolds at the level of cell biology — by restoring metabolic capacities, improving DNA repair, and modulating inflammation-associated signaling pathways. In clinical observations, users report improved skin texture, increased resilience to environmental stressors, and a more even skin surface after regular topical application — effects that occur at the earliest after four to eight weeks of consistent use.

Individual variations are considerable: individuals with pronounced NAD+ deficiency (older age, high UV exposure, chronic sleep deprivation) generally show clearer responsiveness than younger skin with still largely intact NAD+ balance. The synergistic effect with other longevity active ingredients — such as peptides or bakuchiol — can improve the quality of results without impairing individual tolerance. NMN is considered skin-friendly and rarely causes irritation even in sensitive skin.

Frequently Asked Questions

Does topical NMN differ from orally supplemented NMN in its effect on the skin?

Yes, fundamentally. Oral supplementation increases systemic NAD+ levels and thus indirectly affects all tissues — including the skin — via the blood supply. Topical NMN, on the other hand, specifically targets cutaneous cells and can achieve higher local concentrations there without affecting systemic metabolism. For a comprehensive skin longevity strategy, both approaches can be complementary, but they are not equivalently interchangeable.

Is NMN permissible as a cosmetic ingredient under the EU Cosmetics Regulation (EU 1223/2009)?

As of now, NMN does not fall under the restrictions of Annexes II–VI of EU Cosmetics Regulation 1223/2009 and can therefore be used in cosmetic formulations. However, manufacturers are obliged, as part of the product safety assessment (Art. 10), to document concentration, stability, and compatibility in the safety dossier. Therapeutic claims — such as for DNA repair as a medical indication — are not legally permissible in the context of cosmetic product marketing.

Can NMN be combined with Retinol or AHA acids?

Biochemically, there are no known antagonistic interactions. Practically, when combining with AHA acids or retinoids (Vitamin A / Retinoids), a staggered application is recommended — for example, NMN in the morning, retinol in the evening — to avoid unnecessary strain on the skin and to optimally utilize the penetration kinetics of both active ingredients. This sequence logic corresponds to the principle of the circadian skin rhythm.

Conclusion

NMN represents a paradigmatic shift in the scientific conception of skin care: away from purely superficial visual signals, towards the bioenergetic basic supply of the skin cell. As a direct NAD+ precursor, NMN addresses one of the most well-documented biochemical mechanisms of skin aging — the age-associated decline in mitochondrial and regulatory cofactor capacities. In daily care, NMN unfolds its strength not as a single active ingredient, but as an integrative element of a routine focused on skin longevity, which addresses cellular resilience as well as visible surface quality. The evidence base for a cosmetic active ingredient is remarkably solid — and continues to grow.

1. Imai, S., & Guarente, L. (2014). NAD+ and sirtuins in aging and disease. Trends in Cell Biology, 24(8), 464–471. pmc.ncbi.nlm.nih.gov/articles/PMC4112140/
2. Yoshino, J., Baur, J. A., & Imai, S. (2018). NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metabolism, 27(3), 513–528. pmc.ncbi.nlm.nih.gov/articles/PMC5842119/
3. Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141. pmc.ncbi.nlm.nih.gov/articles/PMC7963035/
4. Grozio, A., Mills, K. F., Yoshino, J., Bruzzone, S., Sociali, G., Tokizane, K., … & Imai, S. (2019). Slc12a8 is a nicotinamide mononucleotide transporter. Nature Metabolism, 1(1), 47–57. doi.org/10.1038/s42255-018-0009-4
5. Fang, E. F., Lautrup, S., Hou, Y., Demarest, T. G., Croteau, D. L., Mattson, M. P., & Bohr, V. A. (2017). NAD+ in Aging: Molecular Mechanisms and Translational Implications. Trends in Molecular Medicine, 23(10), 899–916. pmc.ncbi.nlm.nih.gov/articles/PMC5660001/